TITLE

CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH)

AUTHOR(S)
McNeil, Keith; Dunning, John
PUB. DATE
September 2007
SOURCE
Heart;Sep2007, Vol. 93 Issue 9, p1152
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents information on chronic thromboembolic pulmonary hypertension (CTEPH). Chronic pulmonary thromboembolic disease is a significant cause of severe pulmonary hypertension and is related with morbidity and mortality. CTEPH is the only cause of severe pulmonary transplantation that is curable without the need for lung transplantation. It is diagnosed on the basis of radiological investigations executed during the assessment of pulmonary hypertension patient.
ACCESSION #
27040595

 

Related Articles

  • Surgical Treatment of Multivalvular Rheumatic Heart Disease. Berki, Turan; Kísacíko...lu, Bülent; Mete, Atalay; Irez, Aysen; Bayezid, Ömer; Yakut, Cevat // Vascular Surgery;Jun1991, Vol. 25 Issue 5, p337 

    Of 632 valvular heart disease patients 187 were operated on because of multivalvular rheumatic lesions. The operative mortality was 10.1% and late mortality 4.9%. Left ventricular dysfunction was the common cause in the early operative period. Prosthetic valve endocarditis and thromboembolism...

  • Bilateral lung transplantation with intra- and postoperatively prolonged ECMO support in patients with pulmonary hypertension Pereszlenyi, Arpad; Lang, Georg; Steltzer, Heinz; Hetz, Hubert; Kocher, Alfred; Neuhauser, Petra; Wisser, Wilfried; Klepetko, Walter // European Journal of Cardio-Thoracic Surgery;May2002, Vol. 21 Issue 5, p858 

    Objective: Lung transplantation for pulmonary hypertension (PH) is usually performed on cardiopulmonary bypass, with the disadvantage of full systemic anticoagulation, uncontrolled allograft reperfusion and aggressive ventilation. These factors can be avoided with intra- and postoperatively...

  • Erratum.  // Advances in Pulmonary Hypertension;2016, Vol. 15 Issue 2, p112 

    A correction to the article "Pulmonary Arterial Hypertension: 'A Journey to Lung Transplant'" that was published in the previous issue is presented.

  • Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Nunes, H.; Humbert, M.; Capron, F.; Brauner, M.; Sitbon, O.; Battesti, J-P.; Simonneau, G.; Valeyre, D. // Thorax;Jan2006, Vol. 61 Issue 1, p68 

    Background: Pulmonary hypertension (PH) is a rare complication of sarcoidosis, although it is not uncommon in advanced disease. Methods: A retrospective series of 22 sarcoidosis patients (16 men) of mean (SD) age 46 (13) years with PH was divided into two groups depending on the absence (stage...

  • Chronic Thromboembolic Pulmonary Hypertension. Fedullo, Peter F.; Auger, William R.; Kerr, Kim M.; Rubin, Lewis J. // New England Journal of Medicine;11/15/2001, Vol. 345 Issue 20, p1465 

    Discusses the diagnosis and management of chronic thromboembolic pulmonary hypertension. Epidemiology and pathophysiology; Clinical manifestations, including progressive exertional dyspnea and exercise intolerance; Treatment, including pulmonary thromboendarterectomy; Prognosis.

  • Primary pulmonary hypertension.  // British Medical Journal;9/25/1976, Vol. 2 Issue 6038, p718 

    Evaluates the origin of pulmonary hypertension. Manifestation of pulmonary hypertension as a complication of heart and lung diseases; Influence of thromboembolism; Association of the disease with Raynaud's disease.

  • Lung Allocation Score Modification Proposal.  // Advances in Pulmonary Hypertension;Spring2012, Vol. 11 Issue 1, p52 

    The article informs that the Thoracic Organ Transplantation Committee will be reviewing the Lung Allocation Score (LAS) system for increasing the post transplant survival of patients with pulmonary arterial hypertension (PAH).

  • Management Strategies for Improving Outcomes in Pulmonary Arterial Hypertension. Levine, Deborah Jo // Journal of Managed Care Medicine;2012, Vol. 15 Issue 3, p36 

    The article discusses management strategies for improving outcomes in pulmonary arterial hypertension (PAH). PAH is a progressive, fatal disease which encompasses a diverse group of conditions that lead to elevated arterial and/or venous pulmonary pressures, it has nonspecific symptoms and an...

  • Optimal Timing for Lung Transplantation: Why Not Include RVEF As an Indicator? Park, Myung H. // Advances in Pulmonary Hypertension;Spring2012, Vol. 11 Issue 1, p47 

    The article offers information on measuring the optimal time for lung transplantation in pulmonary arterial hypertension (PAH) patients. It mentions that cardiac magnetic resonance imaging (MRI) has the potential to measure the right ventricular (RV) function as prognostic markers in pulmonary...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics